Melanoma arising in association with blue nevus: a clinical and pathologic study of 24 cases and comprehensive review of the literature

被引:37
作者
Loghavi, Sanam [1 ]
Curry, Jonathan L. [1 ]
Torres-Cabala, Carlos A. [1 ]
Ivan, Doina [1 ]
Patel, Keyur P. [2 ]
Mehrotra, Meenakshi [2 ]
Bassett, Roland [3 ]
Prieto, Victor G. [1 ]
Tetzlaff, Michael T. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Sect Dermatopathol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
关键词
blue nevus; cellular blue nevus; melanoma; SUBCUTANEOUS CELLULAR NODULES; MALIGNANT-MELANOMA; CUTANEOUS MELANOMA; LYMPH-NODE; MITOTIC RATE; METASTASIS; SCALP; VALIDATION; VARIANTS; FEATURES;
D O I
10.1038/modpathol.2014.62
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Melanomas arising in association with blue nevi or mimicking cellular blue nevi comprise a relatively rare and heterogeneous group of melanomas. It remains controversial which prognostic indicators predictive of outcome in conventional cutaneous melanomas are applicable to this type of melanoma. Here, we describe the clinical and histopathologic features of 24 melanomas arising in association with blue nevi and correlate these with clinical outcome. The mean patient age was 49 years (range: 23-85) with a slight female predominance (15 females:9 males). The most common anatomic locations included the head and neck region (50%), the trunk (21%), and the buttock/sacrococcygeum (17%). Histologically, the tumors were typically situated in the mid to deep dermis with variable involvement of the subcutis, but uniformly lacked a prominent intraepithelial component. The mean tumor thickness (defined as either the standard Breslow thickness or, if not available due to the lack of orientation or lack of epidermis, the largest tumor dimension) was 20.9 mm (range: 0.6-130 mm). The mean mitotic figure count was 6.5/mm(2) (range: 1-30/mm(2)). Perineural invasion was common (38%). Follow-up was available for 21 cases (median 2.1 years). The median overall survival, recurrence-free survival, time to local recurrence, and time to distant recurrence were 5.2, 0.7, 2.6, and 1.6 years, respectively. Logistic regression analyses demonstrated a significant association between tumor thickness and recurrence-free survival (hazard ratio = 1.02 per mm; P=0.04) and reduced time to distant metastasis (hazard ratio = 1.03 per mm; P=0.02) with a similar trend toward reduced time to local recurrence (hazard ratio = 1.02 per mm; P=0.07). No other parameters (age, anatomic location, mitotic figures, lymphovascular or perineural invasion, or type of associated blue nevus) emerged as significant. In addition, we provide a comprehensive review of 109 cases of melanoma blue nevus type described in the English literature and summarize our findings in this context.
引用
收藏
页码:1468 / 1478
页数:11
相关论文
共 67 条
  • [1] ALLEN AC, 1953, CANCER-AM CANCER SOC, V6, P1, DOI 10.1002/1097-0142(195301)6:1<1::AID-CNCR2820060102>3.0.CO
  • [2] 2-C
  • [3] Malignant cellular blue nevus - A clinicopathological study of 6 cases
    Aloi, F
    Pich, A
    Pippione, M
    [J]. DERMATOLOGY, 1996, 192 (01) : 36 - 40
  • [4] Malignant blue Nevus - A case report and molecular analysis
    Ariyanayagam-Baksh, SM
    Baksh, FK
    Finkelstein, SD
    Swalsky, PA
    Abernethy, J
    Barnes, EL
    [J]. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2003, 25 (01) : 21 - 27
  • [5] ATYPICAL BLUE NEVUS - BENIGN VARIANT OF CELLULAR BLUE NEVUS - PRESENTATION OF 3 CASES
    AVIDOR, I
    KESSLER, E
    [J]. DERMATOLOGICA, 1977, 154 (01): : 39 - 44
  • [6] Final Version of 2009 AJCC Melanoma Staging and Classification
    Balch, Charles M.
    Gershenwald, Jeffrey E.
    Soong, Seng-jaw
    Thompson, John F.
    Atkins, Michael B.
    Byrd, David R.
    Buzaid, Antonio C.
    Cochran, Alistair J.
    Coit, Daniel G.
    Ding, Shouluan
    Eggermont, Alexander M.
    Flaherty, Keith T.
    Gimotty, Phyllis A.
    Kirkwood, John M.
    McMasters, Kelly M.
    Mihm, Martin C., Jr.
    Morton, Donald L.
    Ross, Merrick I.
    Sober, Arthur J.
    Sondak, Vernon K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) : 6199 - 6206
  • [7] CUTANEOUS MELANOMA - PROGNOSIS AND TREATMENT RESULTS WORLDWIDE
    BALCH, CM
    [J]. SEMINARS IN SURGICAL ONCOLOGY, 1992, 8 (06): : 400 - 414
  • [8] Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system
    Balch, CM
    Soong, SJ
    Gershenwald, JE
    Thompson, JF
    Reintgen, DS
    Cascinelli, N
    Urist, M
    McMasters, KM
    Ross, MI
    Kirkwood, JM
    Atkins, MB
    Thompson, JA
    Coit, DG
    Byrd, D
    Desmond, R
    Zhang, YT
    Liu, PY
    Lyman, GH
    Morabito, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) : 3622 - 3634
  • [9] Atypical cellular blue Nevi (cellular blue nevi with atypical features): Lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus")
    Barnhill, Raymond L.
    Argenyi, Zsolt
    Berwick, Marianne
    Duray, Paul H.
    Erickson, Lori
    Guitart, Joan
    Horenstein, Marcello G.
    Lowe, Lori
    Messina, Jane
    Paine, Susan
    Piepkorn, Michael W.
    Prieto, Victor
    Rabkin, Michael S.
    Schmidt, Birgitta
    Selim, Angelica
    Shea, Chris R.
    Trotter, Martin J.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2008, 32 (01) : 36 - 44
  • [10] The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma
    Barnhill, RL
    Katzen, J
    Spatz, A
    Fine, J
    Berwick, M
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2005, 32 (04) : 268 - 273